APH vs HOTH · P/E 40, rev $23.09B vs rev $1.24B
Amphenol Corporation (APH) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the APH and HOTH stock pages for the full models.
Not investment advice.